Back
Cleveland-Cliffs Vs. Longboard Pharmaceuticals Industry Stock Comparison
Sell
35
CLF
Cleveland-Cliffs
Last Price:
12.97
Seasonality Move:
8.04%
Buy
51
LBPH
Longboard Pharmaceuticals
Last Price:
36.43
Seasonality Move:
-17.08%
Sell
35
Cleveland-Cliffs (CLF)
is a Sell
Is Cleveland-Cliffs a Buy, Sell or Hold?
- The current Cleveland-Cliffs [CLF] share price is $12.99. The Score for CLF is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- CLF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
51
Longboard Pharmaceuticals (LBPH)
is a Buy
Is Longboard Pharmaceuticals a Buy, Sell or Hold?
- The current Longboard Pharmaceuticals [LBPH] share price is $37.15. The Score for LBPH is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- LBPH is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CLF Stock Price Chart
What is Cleveland-Cliffs's stock price today?
-
The Cleveland-Cliffs share price today is $12.99
The current trend is relatively stagnant and CLF is experiencing buying pressure, which is a positive indicator for future bullish movement.
LBPH Stock Price Chart
What is Longboard Pharmaceuticals's stock price today?
-
The Longboard Pharmaceuticals share price today is $37.15
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LBPH is experiencing slight buying pressure.
CLF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 57.95 | Buy |
| Chaikin Money Flow: | 7234960 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.39 - 12.95) | Buy |
| Bollinger Bands (100): | (12.58 - 16.42) | Sell |
LBPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.16 | Sell |
| Relative Strength Index (14 RSI): | 60.09 | Buy |
| Chaikin Money Flow: | 172834 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (31.32 - 35.6) | Buy |
| Bollinger Bands (100): | (22.04 - 36.62) | Buy |
CLF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.44 | Buy |
| 20-day SMA: | 11.91 | Buy |
| 50-day SMA: | 12.96 | Buy |
| 200-day SMA: | 17.22 | Sell |
| 8-day EMA: | 12.53 | Buy |
| 20-day EMA: | 12.34 | Buy |
| 50-day EMA: | 13.03 | Sell |
| 200-day EMA: | 15.72 | Sell |
LBPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 33.06 | Buy |
| 20-day SMA: | 33.03 | Buy |
| 50-day SMA: | 34.22 | Buy |
| 200-day SMA: | 24.38 | Buy |
| 8-day EMA: | 33.39 | Buy |
| 20-day EMA: | 33.24 | Buy |
| 50-day EMA: | 32.83 | Buy |
| 200-day EMA: | 24.82 | Buy |
Cleveland-Cliffs Earnings Growth & CLF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.45 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.09 per share, and an increase next year of $0.76 per share.
Longboard Pharmaceuticals Earnings Growth & LBPH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.21 per share, and a decrease next year of $0.53 per share.
Cleveland-Cliffs Technical Analysis
| Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Longboard Pharmaceuticals Technical Analysis
| Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||